Compounding Quality

Compounding Quality

Share this post

Compounding Quality
Compounding Quality
10 Stocks For 2025
Copy link
Facebook
Email
Notes
More
Investment cases

10 Stocks For 2025

Start 2025 the right way

Compounding Quality's avatar
Compounding Quality
Dec 29, 2024
∙ Paid
125

Share this post

Compounding Quality
Compounding Quality
10 Stocks For 2025
Copy link
Facebook
Email
Notes
More
9
Share

Are you ready for 2025?

Great things happen to those who prepare.

Here are 10 interesting stock ideas to kickstart the new year.

Buy & Sell Ideas for June 10: Top two stocks picked by Anand Rathi | News  on Markets - Business Standard

10. Visa/Mastercard ($V/$MA)

Company Profile

Visa and Mastercard dominate the global digital payment industry.

These companies operate networks that facilitate electronic transactions between consumers and businesses worldwide.

Instead of issuing cards, they partner with banks, earning fees for every transaction processed through their systems.

Investment Rationale

  • A very profitable duopoly dominating the industry

  • One of the strongest network effects in the world

  • The US Digital Payment Market is expected to grow at a CAGR of 21.1% (!) per year until 2030

Source: Finchat

9. Ameriprise Financial ($AMP)

Company Profile

Ameriprise Financial provides wealth management, financial planning, and insurance services.

Their primary focus is helping individuals and institutions manage investments for long-term growth.

Investment Rationale

  • Cannibal stock (buyback yield of up to 9%)

  • Excellent management and capital allocation strategy

  • CAGR since IPO in 2005: 17.4%

Source: AMP’s investor presentation

8. Sanlorenzo ($SL)

Company Profile

Sanlorenzo designs and manufactures luxury yachts for high-net-worth individuals.

The Italian company combines traditional craftsmanship with cutting-edge design, creating some of the most sought-after yachts in the world.

Sanlorenzo’s clientele appreciates exclusivity, and the company limits production to maintain its premium brand positioning.

Investment Rationale

  • The luxury market is very attractive

  • CAGR since IPO in 2019: 16.6%

  • Amazing growth: 5-year EPS CAGR: 45.2%

Source: Finchat

7. HG Capital Trust ($HGT)

Company Profile

HG Capital Trust is a listed private equity vehicle that invests in software and tech-enabled businesses.

The trust focuses on sectors like SaaS (Software as a Service), healthcare IT, and business services.

Their active ownership model helps portfolio companies scale effectively.

Investment Rationale

  • Revenue and EBITDA of HGT’s top 20 companies have grown by 20–30% per year

  • HgT is a leading investor in unlisted software and services companies

  • In the very long term, Private Equity performs even better than stocks

Source: HgT’s investor presentation

6. Medpace ($MEDP)

Company Profile

Medpace is a clinical contract research organization (CRO) that partners with pharmaceutical and biotech companies to run clinical trials.

With expertise in niche therapeutic areas, Medpace helps efficiently market new drugs and treatments.

Investment Rationale

  • Clinical Research Organizations (CROs) are very profitable

  • August Troendle founded the company in 1992 and he's still the CEO today

  • Long-term estimated EPS-Growth: 15.2%

Source: Finchat

5. Topicus ($TOI)

Company Profile

Topicus is a serial acquirer of Vertical Market Software (VMS) businesses. It’s a spin-off from Constellation Software, one of the best compounders in the world.

A VMS business creates software designed to solve industries' unique needs. As a result, it usually dominates a niche market because its products are hard to replace.

Investment Rationale

  • Moat based on switching costs

  • Mark Leonard (one of the best capital allocators) is on the board of Topicus

  • Still a long runway ahead

Source: Nicoper’s Notes

4. Kinsale Capital ($KNSL)

Company Profile

Kinsale Capital is a specialty insurer focused on excess and surplus lines.

The company takes on risks that standard insurers avoid, leveraging its deep expertise and efficient underwriting process.

Investment Rationale

  • The company wants to double its market share in the next few years

  • Founder Michael Kehoe is an excellent CEO

  • Strong growth figures - 10-year Revenue CAGR: 38.1%

Source: Finchat

Now let’s dive into the top 3.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Compounding Quality
Publisher Privacy
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More